Immunological monitoring and clinical trials of biological response modifiers.
Urba
W J
WJ
Baseler
M W
MW
D002986:Clinical Trials as Topic; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology* / Q000627:therapeutic use*; D007370:Interferon Type I / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D015166:Monitoring, Immunologic; D009369:Neoplasms / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D007155:Immunologic Factors; D007370:Interferon Type I; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma